Loading...
We have set up our new Discord server! Share your feedback and find like-minded people! Join our Discord
- Ticker
- OMIC
- Price
- -
- Stock movement up
- +- (%)
- Company name
- Singular Genomics Systems Inc
- Exchange
- (NASDAQ ,
- Currency
- USD )
- Sector
- Healthcare >Medical Instruments & Supplies
- Market cap
- 50.77M
- Ent value
- 61.44M
- Price/Sales
- 19.04
- Price/Book
- 0.41
- Div yield
- -
- Div growth
- -
- Growth years
- -
- FCF payout
- -
- Trailing P/E
- -
- Forward P/E
- -
- PEG
- -
- EPS growth
- -
- 1 year return
- 26.09%
- 3 year return
- -55.89%
- 5 year return
- -
- 10 year return
- -
Last updated: 2025-09-15
DIVIDENDS
OMIC does not pay dividends or no data was received
VALUATION
Valuation Ratios
Loading...
Valuation Ratios data
| Trailing P/E | - |
| Price to OCF | - |
| Price to FCF | - |
| Price to EBITDA | - |
| EV to EBITDA | - |
Valuation (Sales/Book Value)
Loading...
Valuation (Sales/Book Value) data
| Price to Sales | 19.04 |
| Price to Book | 0.41 |
| EV to Sales | 23.05 |
FINANCIALS
Per share
Loading...
Per share data
| Current share count | 2.54M |
| EPS (TTM) | - |
| FCF per share (TTM) | - |
Income statement
Loading...
Income statement data
| Revenue (TTM) | - |
| Gross profit (TTM) | - |
| Operating income (TTM) | - |
| Net income (TTM) | - |
| EPS (TTM) | - |
| EPS (1y forward) | -31.28 |
Margins
Loading...
Margins data
| Gross margin (TTM) | - |
| Operating margin (TTM) | - |
| Profit margin (TTM) | - |
Balance Sheet
Loading...
Please create a free account or log in to access this chart
Balance Sheet data
| Cash | 52.62M |
| Net receivables | 1.01M |
| Total current assets | 129.81M |
| Goodwill | 0.00 |
| Intangible assets | 0.00 |
| Property, plant and equipment | 0.00 |
| Total assets | 186.55M |
| Accounts payable | 1.88M |
| Short/Current long term debt | 50.49M |
| Total current liabilities | 17.61M |
| Total liabilities | 63.30M |
| Shareholder's equity | 123.25M |
| Net tangible assets | 0.00 |
Cash flow
Loading...
Please create a free account or log in to access this chart
Cash flow data
| Operating cash flow (TTM) | - |
| Capital expenditures (TTM) | - |
| Free cash flow (TTM) | - |
| Dividends paid (TTM) | - |
Financial returns
Loading...
Please create a free account or log in to access this chart
Financial returns data
| Return on Equity | - |
| Return on Assets | - |
| Return on Invested Capital | - |
| Cash Return on Invested Capital | - |
STOCK INFORMATION
Downside potential
Loading...
Downside potential data
| OMIC | S&P500 | |
| Current price drop from All-time high | -97.86% | -2.12% |
| Highest price drop | -99.40% | -19.00% |
| Date of highest drop | 12 Sep 2024 | 8 Apr 2025 |
| Avg drop from high | -86.26% | -2.76% |
| Avg time to new high | 313 days | 5 days |
| Max time to new high | 937 days | 89 days |
COMPANY DETAILS
Marketcap
50.77M
Marketcap category
Small-cap
Description
Singular Genomics Systems, Inc., a life science technology company, develops next generation sequencing and spatial multiomics technology for researchers and clinicians to advance science and medicine. It is involved in the developing of G4, consisting of G4 instrument and associated consumables for various applications, such as max read kits for single cell sequencing, rare variant detection with high-definition sequencing, gene fusion detection with ring-seq, and extended range sequencing; and PX instrument and associated consumables focusing on the single cell and spatial analysis markets. The company was incorporated in 2016 and is based in San Diego, California. As of February 21, 2025, Singular Genomics Systems, Inc. was taken private.
Employees
255
Investor relations
-
SEC filings
CEO
Country
USA
City
Stock type
-
CCC status
-
Dividend Frequency
-
EVENTS AND PRESENTATIONS
EventsPresentations
Loading...
UNDERSTAND THE BUSINESS
Loading...
COMPANY NEWS
Seeking AlphaPress releases
No items found
iO Charts is a Seeking Alpha partner